Robert Rush challenges the DEA’s evidence and proposed Schedule I classification of five tryptamines

Attorney Robert T. Rush discusses the DEA’s proposal to place five tryptamines - 4-OH-DiPT, 5-MeO-AMT, 5-MeO-MiPT, 5-MeO-DET, and DiPT - in Schedule I. He challenges the evidence used by the government, including disputed reliance on Reddit posts and safety claims involving poison-center data, and explains how restrictive scheduling could obstruct research, drug development, and academic work. The conversation also covers the DOI/DOC proceedings, cognitive liberty, reform of the Controlled Substances Act, judicial review, and the distinction between submitting a public comment and requesting a formal hearing. Listeners are urged to participate in the rulemaking process before October 23, 2026, while researchers whose work could be affected are invited to contact Rush’s Rights and Reason Project.